Geode Capital Management
AURA icon

Geode Capital Management’s Aura Biosciences AURA Stock Holding History

Geode Capital Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5M Buy
1,754,721
+443,859
+34% +$3.18M ﹤0.01% 2423
2026
Q1 		$8.77M Buy
1,310,862
+55,412
+4% +$318K ﹤0.01% 2456
2025
Q4 		$6.85M Sell
1,255,450
-2,497
-0.2% -$14.8K ﹤0.01% 2597
2025
Q3 		$7.78M Buy
1,257,947
+327,973
+35% +$2.14M ﹤0.01% 2558
2025
Q2 		$5.82M Sell
929,974
-95,582
-9% -$559K ﹤0.01% 2649
2025
Q1 		$6.01M Buy
1,025,556
+12,757
+1% +$96.5K ﹤0.01% 2571
2024
Q4 		$8.33M Buy
1,012,799
+3,972
+0.4% +$37.4K ﹤0.01% 2479
2024
Q3 		$8.99M Buy
1,008,827
+39,379
+4% +$338K ﹤0.01% 2448
2024
Q2 		$7.33M Buy
969,448
+188,258
+24% +$1.38M ﹤0.01% 2511
2024
Q1 		$6.13M Buy
781,190
+105,062
+16% +$871K ﹤0.01% 2581
2023
Q4 		$5.99M Buy
676,128
+149,690
+28% +$1.27M ﹤0.01% 2614
2023
Q3 		$4.72M Buy
526,438
+26,842
+5% +$289K ﹤0.01% 2668
2023
Q2 		$6.17M Buy
499,596
+41,688
+9% +$446K ﹤0.01% 2578
2023
Q1 		$4.25M Buy
457,908
+157,435
+52% +$1.64M ﹤0.01% 2708
2022
Q4 		$3.15M Buy
300,473
+11,161
+4% +$142K ﹤0.01% 2878
2022
Q3 		$5.24M Buy
289,312
+82,018
+40% +$1.24M ﹤0.01% 2647
2022
Q2 		$2.94M Buy
207,294
+101,960
+97% +$1.69M ﹤0.01% 2976
2022
Q1 		$2.32M Buy
105,334
+3,259
+3% +$62.1K ﹤0.01% 3186
2021
Q4 		$1.73M Buy
+102,075
New +$1.82M ﹤0.01% 3440

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Geode Capital Management's AURA Position: Q2 2026 in Review

Geode Capital Management increased its Aura Biosciences (AURA) stake by 34% in Q2 2026, buying an estimated $3.18M and bringing the position to 1,754,721 shares worth $12.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2423.

Geode Capital Management first reported a position in AURA in Q4 2021 and has held it in 19 quarters since. 146 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Geode Capital Management held 1,754,721 shares of Aura Biosciences worth $12.5M as of Q2 2026.
  • Geode Capital Management bought 443,859 Aura Biosciences shares in Q2 2026, an estimated $3.18M.
  • Aura Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2423 holding.
  • Geode Capital Management first reported a position in Aura Biosciences in Q4 2021 and has held it in 19 quarters since.
  • 146 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.